Best of BS Opinion: Opportunities galore in the east, Covid crisis & more

Here are the best of Business Standard's opinion pieces for Thursday

India has faltered at multiple levels in the rollout of its vaccination programme. As a result, the pace is much lower than desired. Bharat Biotech, for instance, on Tuesday said the government’s procurement price at Rs 150 per dose for Covaxin was not sustainable in the long run. This effectively means that the firm has little or no incentive to increase production, which can directly affect the vaccine rollout. In this context our lead editorial argues that India’s covid-19 vaccination programme should not suffer because of less-than- adequate planning. Read here
 

Efforts by India to get back Mehul Choksi will depend to a large extent on the response to the request for his repatriation from Dominica. The problem however is compounded by the fact that Dominica does not figure in the list of countries with which India has an extradition treaty or arrangement, writes Shyamal Majumdar
 

A deeper integration with East Asian economies could be integral to India’s economic recovery in the pandemic, writes Amita Batra

  

Quote

“There are numerous queries arising as to whether Twitter is entitled to safe harbour provision. However, the simple fact of the matter is that Twitter has failed to comply with the intermediary guidelines that came into effect from May 26.”

Minister for Electronics and Information Technology Ravi Shankar Prasad